

Coumadin beats DOAC, ECMO fails, When RCTs needed, Bad COVID Policy
Sep 11, 2023
Topics discussed include harmful medical treatments discovered through randomized controlled trials, risks and benefits of COVID boosters, changes in COVID-19 vaccine eligibility criteria, critical analysis of ECMO and viral swab tests, and the importance of randomized studies and cultivating a culture of curiousness.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 3min
Uncovering Harmful Medical Treatments through Randomized Controlled Trials
02:36 • 26min
Risks and Benefits of COVID Boosters: Addressing the Risk of Myocarditis and Side Effects
28:11 • 2min
Changes in COVID-19 Vaccine Eligibility Criteria and Perspectives on Healthcare Practices
30:34 • 11min
ECMO, COVID-19, and Uselessness of Viral Swab Tests
41:32 • 3min
The Importance of Randomized Studies and Cultivating a Culture of Curiousness
44:23 • 4min